Dandruff is not a hygiene problem. It is an ecological imbalance.
For a long time, dandruff was seen as a sign of poor personal care. That is simply not true. Dandruff is a chronic scalp condition in which the balance of the microbiome — the ecosystem of micro-organisms living on your scalp — becomes disrupted.
On a healthy scalp, bacteria and yeasts coexist in balance. The three most prevalent micro-organisms are Malassezia (a yeast species), Cutibacterium acnes and species of Staphylococcus. Research published in the British Journal of Dermatology (2024) shows that in people with dandruff, this balance shifts significantly: Malassezia restricta increases, Cutibacterium acnes declines, and Staphylococcus capitis becomes more dominant.¹
This disruption has consequences. Malassezia feeds on the fatty acids in sebum and produces irritating by-products in the process. These by-products damage the skin barrier, accelerate cell turnover and cause the visible flaking, itching and redness we know as dandruff.
The goal of effective treatment is therefore not simply to 'kill the yeast', it is to restore balance.
Why conventional treatments fall short
For decades, the anti-dandruff category was dominated by zinc pyrithione, ketoconazole, selenium sulphide and piroctone olamine. These are broad-spectrum antifungals: they suppress Malassezia, but they do not distinguish between beneficial and harmful micro-organisms.
The result: once you stop using the product, dandruff returns, sometimes faster than before. That is because the underlying imbalance was never addressed. Furthermore, zinc pyrithione was banned in the EU in 2022 over concerns about reproductive toxicity.²
There was a clear need for a new approach. One that is more selective, more effective over the long term, and safe for daily use.
What are peptides?
Peptides are short chains of amino acids, the building blocks of proteins. They occur naturally in the human body and play a key role in countless biological processes: from cell communication and tissue repair to immune responses.
Peptides have been used in skincare for more than twenty years. In premium anti-ageing products, they have become a gold standard, valued for their ability to steer cellular processes without placing stress on the skin. They work with precision: they communicate with specific cells or micro-organisms in a way the body naturally recognises.
Calmbay now applies this technology, proven in skincare for years, to the scalp.
The active ingredient: hLF1-11
At the heart of the Calmbay formula is hLF1-11, a synthetic peptide inspired by lactoferrin, a protein found naturally in human breast milk and saliva, and one that plays a central role in the body's defences.
The full lactoferrin protein has antimicrobial and immunomodulatory properties. Researchers discovered that the a specific group of 11 amino acids are responsible for a significant portion of this biological activity.³ This fragment was named hLF1-11.
hLF1-11 is bio-identical: it mirrors a mechanism the body uses itself. That is the essence of biomimetic technology: not introducing something foreign, but amplifying what the body already knows.
How does hLF1-11 work?
Scientific research published in Antimicrobial Agents and Chemotherapy and confirmed in recent studies (2024) demonstrates that hLF1-11 works on multiple levels simultaneously.³⁴
1. Direct antifungal action hLF1-11 binds to the cell wall of Malassezia yeast and disrupts its integrity. This leads to cytolysis: the breaking down and destruction of the fungal cell. Research published in 2024 in Antibiotics (MDPI) demonstrated that hLF1-11 is effective against 30 different strains of Malassezia furfur, the yeast species associated with seborrhoeic dermatitis and pityriasis versicolor.⁴
An additional mechanism: lactoferrin-derived peptides sequester iron from the surrounding environment (iron scavenging). Because Malassezia depends on iron for growth and virulence, the fungus is indirectly deprived of a critical resource.⁴
2. Strengthening the skin's natural defences hLF1-11 has demonstrated immunomodulatory effects. It stimulates monocytes (a type of immune cell) to respond more effectively to threats. Research published in The Journal of Immunology shows that hLF1-11 inhibits the enzymatic activity of myeloperoxidase (MPO), thereby regulating the inflammatory response without suppressing the immune system.⁵
This is a subtle but important distinction from conventional antifungals: Calmbay does not suppress the immune response, it modulates it. The body learns to manage the imbalance more effectively, rather than becoming dependent on an external agent.
3. Synergistic action with other active ingredients Research has shown that hLF1-11 works synergistically with fluconazole, a conventional antifungal.⁶ This means the combination is more powerful than the sum of its parts. This principle of amplifying the performance of other active ingredients, makes hLF1-11 particularly well-suited as a core ingredient in a leave-in formula, where actives have optimal time to interact with the scalp.
Leave-in: the key to time-on-scalp
Calmbay has been deliberately developed as a leave-in treatment, not a shampoo. That choice is scientifically grounded.
Shampoos are rinsed off: active ingredients have literally only seconds to minutes of contact with the scalp. For a peptide whose action is based on cellular interaction, that is insufficient. hLF1-11 needs time to work: to reach the cell walls of Malassezia, to activate immune cells and to rebalance the microbiome.
The Eurofins study conducted on behalf of Calmbay (2025) confirms this. In 30 participants with sensitive scalp and dandruff, statistically significant improvements in erythema (redness), itching, and both adherent and non-adherent dandruff were measured after just 10 days of twice-daily application. After 60 days, the average dandruff score had decreased by more than 80%. No adverse events were recorded.⁷
Safety as a starting point
A treatment that works but stresses the skin is not a good treatment. hLF1-11 is derived from a protein that occurs naturally in the human body. It has an excellent safety profile for daily use, a quality that has been studied in both in-vitro and clinical settings.
The Calmbay formula deliberately contains only what is necessary. No unnecessary fragrance compounds. No aggressive preservatives. No ingredients that needlessly disrupt the microbiome.
The future of dandruff treatment
The science is clear: dandruff calls for an integrated approach that respects the microbiome, supports the skin barrier, and addresses the root cause rather than the symptom. That requires a new generation of active ingredients — selective, biomimetic and proven.
hLF1-11 meets all of those criteria. Calmbay is the first cosmetic line to translate this peptide technology into a daily, premium anti-dandruff scalp treatment. Precise, effective and pleasant to use.
References
¹ Liang B. et al. Dandruff scalp microbiome exhibits flake severity and sex-related differences. British Journal of Dermatology Supplements, 2024.
² European Commission. Regulation (EU) 2021/1902, ban on zinc pyrithione in cosmetic products.
³ Lupetti A. et al. Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrobial Agents and Chemotherapy, 2003; 47(1): 262–267.
⁴ Brouwer CPJM, Theelen B, van der Linden Y, Sarink N, Rahman M, Alwasel S, Cafarchia C, Welling MM, Boekhout T. Combinatory Use of hLF(1-11), a Synthetic Peptide Derived from Human Lactoferrin, and Fluconazole/Amphotericin B against Malassezia furfur Reveals a Synergistic/Additive Antifungal Effect. Antibiotics (Basel). 2024 Aug 22;13(8):790. PMID: 39200089. PMC11351325
⁵ Van der Does A.M. et al. The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. The Journal of Immunology, 2012.
⁶ Lupetti A. et al. Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrobial Agents and Chemotherapy, 2003.
⁷ Eurofins EVIC Romania. Evaluation of the anti-dandruff effect and the soothing effect of the Calmbay Anti-Dandruff Treatment (CB25003D). Final study report, December 2025.

